2012 Annual Meeting in Tampa, FL, April 29-May 2
Leadership Lessons Learned
All pharmacy practitioners are leaders in that we are all change agents and influencers of the thinking of our patients, students, and colleagues. Dr. Wells’ presentation is designed to help you select strategies to maximize your ability to bring about change in your professional setting and realize your potential to build programs, improve the care of patients, and increase your personal effectiveness.
2006 Annual Meeting Schedule
Sunday, April 23, 2006: Pre-Meeting Workshop
Scheduled for Sunday, April 23, this half-day, behavioral and movement disorder rating scale workshop will improve attendees' ability to understand and administer these scales and use the acquired skills to better interpret and evaluate pertinent published literature. CPNP has partnered with Pharmastar, a global leader in rater qualification and training services in the area of central nervous system therapeutics to provide this workshop. Workshop leaders will utilize patient scenarios and interactive instructional techniques to enhance the attendees' knowledge of the Positive and Negative Syndrome Scale (PANSS) as well as various movement disorder rating scales. A modest registration fee is required to attend this pre-meeting workshop. A light breakfast, lunch and break items are included.
Sunday, April 23, 2006: Evidence-Based Practice Programming
Eligible for Board Certified Psychiatric Pharmacy Recertification Credit, these 5 hours of programming kick off the meeting by providing therapeutic, evidence-based content offering practical application for those in any setting. These sessions are of great value to all attendees. This programming is included within the full Annual Meeting and Sunday one-day registration options at no additional fee. Additional fees apply for those requiring recertification credit.
Monday, April 24, 2006: Keynote Address
Joyce Burland, Director of Education for NAMI, focuses attendees on the most important element of our profession--the consumers and family members dealing with mental illness. Dr. Burland will address the stages of mental illness and the needs of affected consumers and family members.
Tuesday, April 25, 2006: CATIE Trial-Implications for Clinical Practice
Get the latest information on the CATIE Trial. From one of the trial principals, Dr. Richard Keefe of Duke University Medical Center. Emphasis will be placed on primary efficacy measures and their clinicla meeting as well as the potential impact of the trial on national treatment guidelines. Investigator Dr. Roger Sommi will lead discussion regarding the role of psychiatric pharmacists in appropriate antipsychotic use.
Tuesday, April 25, 2006: Concurrent Programming
Eight hours of concurrent programming provide an array of sessions for attendees to choose from to best meet their individual needs. Delve more into personality disorders, substance abuse patient management or listen to up to 10 platform presentations presented by award finalists.
Tuesday, April 25, 2006: Awards Banquet
Join your colleagues in recognizing the contributions of outgoing CPNP President Charles Caley, PharmD, BCPP and welcoming incoming President Matthew Fuller, PharmD, BCPS, BCPP, FASHP as he is installed as the 9th president of CPNP. Experience the reflections of Judith J. Saklad Memorial Lecture Award recipient James Wilson, PharmD, instrumental in the formation of CPNP and one of the early pioneers in the field of psychiatric and neurologic pharmacy.
Wednesday, April 26, 2006: Neurology Programming
Capping off the Annual Meeting is an update on the management and treatment of Parkinson's Disease and Multiple Sclerosis. Drs. Jack Chen and Fred Lublin provide practical information for immediate application in your practice setting.
Sunday, April 23, 2006
| 8:00 - 11:00 am |
Pre-Meeting Workshop Rating Scales Training-Movement and Behavioral Rating Scales (Additional registration and fees required for participation) Steve Targum, MD or David Miller, MD |
|
| Evidence-Based Practice Programming | ||
|---|---|---|
| 12:00 pm | Opening Remarks* | |
| 12:15 pm | Evaluating Clinical Trials in Anxiety Disorders+ | Laura Mandos, PharmD |
| 1:15 pm | Phamacological Basis of Treatment of Schizophrenia+ | Sheila Botts, PharmD, BCPP |
| 2:30 pm | Treatment Resistant Depression+ | Lynn Crismon, PharmD, BCPP |
| 3:30 pm | Autistic Disorder and Other Pervasive Developmental Disorders+ | William H. Benefield, Jr., PharmD, BCPP, FASCP |
| 4:45 - 5:45 pm | Personality Disorders: Clinical Diagnosis and Evidence-Based Treatment+ | Sally Guthrie, PharmD, BCPP |
| 6:30 - 9:30 pm | Industry Symposium 1** | |
Monday, April 24, 2006
| 8:30 am |
Keynote Address Improving Patient Care through the Experiences of Consumers and Families |
Joyce Burland, PhD |
| Personality Disorders | ||
|---|---|---|
| 9:40 am | Psychotherapy: What do Psychiatric Pharmacists Need to Know? | Maria Llana-Posey, MA, PharmD, BCPP |
| 11:00 am | The Treatment of Borderline Personality Disorder -- Incorporating DBT and Pharmacotherapy | Shelley McMain, PhD |
| 12:00 - 2:30 pm | Industry Symposium 2** | |
| The Impact of Government and Industry | ||
| 2:40 pm | The Medicare Modernization Act--Impact on Pharmacy Practice | Susan Winckler, RPh, Esq |
| 4:00 - 5:00 pm | The Value of Psychiatric Medication Debate Industry and Managed Care Perspectives |
Dan Buffington, PharmD, MBA Daniel Dugan, PharmD, BCPP |
| 5:30 pm | Exhibitor and President's Reception* | |
| 6:30 - 9:30 pm | Industry Symposium 3** | |
Tuesday, April 25, 2006
| 7:00 - 9:00 am | Industry Symposium 4** | |
| CATIE Trial | ||
|---|---|---|
| 9:15 am | CATIE Trial: Implications for Clinical Practice |
Richard Keefe, PhD Roger Sommi, PharmD, BCPP, FCCP |
| Substance Use Treatment | ||
| 10:30 am | Substance Dependence: Current Trends and Treatment Dilemmas | Mary Jeane Kreek, MD |
| 11:30 am | Substance Dependence Concurrent Programming | |
| Breakout 1: Opioid Dependence: Highlighting Buprenorphine Treatment | Tony Tommasello, MS, PhD | |
| Breakout 2: The Pharmacologic Basis for Alcohol Use Disorders and Treatment | George Kenna, RPh, PhD | |
| 12:30 - 5:00 pm | Poster/Exhibit Viewing* (Poster and booths are manned during luncheon from 12:30 - 2:00 pm) | |
| 2:10 - 3:10 pm | Ask the Experts Concurrent Programming | |
| Breakout 3: Managing Patients with Substance Abuse Panel |
Tony Tommasello, MS, PhD George Kenna, RPh, PhD Julie Kissack, PharmD, BCPP |
|
| Breakout 4: Motivational Interviewing: Application in Psychopharmacology | Peter Selby, MBBS, CCFP, MHSc, ASAM | |
| Breakout 5: Platform Presentations* | ||
| 3:40 - 4:40 pm | Training the Experts Concurrent Programming | |
| Breakout 6: How to Work Effectively with Patients with Personality Disorders | John Spollen, III, MD | |
| Breakout 7: Best Practices: eRx in Clinical Practice | Hank Rappaport, MD | |
| Breakout 8: Platform Presentations* | ||
| 5:45 pm | Awards Banquet & Reception* | |
| 6:30 - 9:30 pm | Awards Banquet and Judith J. Saklad Memorial Lecture* | James Wilson, PharmD |
Wednesday, April 26, 2006
| 7:30 am | Town Hall Breakfast and Meeting* | |
| 8:00 am - 12:00 pm | Poster Viewing* (Posters are not manned) | |
| Neurology Update | ||
|---|---|---|
| 9:45 am | Beyond the Mask of Parkinson's Disease | Jack J. Chen, PharmD, BCPS, CGP |
| 11:00 am - 12:00 pm | Advances in the Treatment of Multiple Sclerosis | Fred Lublin, MD |
All sessions are approved for ACPE and Nursing continuing education credit unless otherwise noted:
** Not Approved for Nursing Credit
+ Approved for BCPP Recertification, ACPE and Nursing Credit
Attire
Business casual attire is recommended throughout the Annual Meeting except for the Awards Banquet when business attire is recommended.